Hino, Japan

Yuko Kato

This inventor holds 1 USPTO granted patent. Top assignee: Teijin Pharma Limited. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yuko Kato. Retrieved from https://idiyas.com/inventor/yuko-kato-b1qbd1b9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yuko Kato: Innovator in Pharmaceutical Compounds

Introduction

Yuko Kato is a notable inventor based in Hino, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of bone diseases. Her innovative work has led to the development of a patent that addresses critical health issues.

Latest Patents

Yuko Kato holds a patent for compounds that are effective in treating Paget's disease of bone, hypercalcemia, or osteoporosis. The patent describes compounds expressed by a specific formula, which includes various C-Calkyl and C-Caralkyl groups. These compounds are designed to provide therapeutic benefits for patients suffering from these conditions.

Career Highlights

Kato's career is marked by her dedication to pharmaceutical research and development. She works at Teijin Pharma Limited, where she collaborates with other talented professionals in the industry. Her work has been instrumental in advancing treatments that improve patient outcomes.

Collaborations

Yuko Kato has collaborated with notable colleagues, including Kazuo Nagasawa and Yuichi Hashimoto. These partnerships have fostered a creative environment that encourages innovation and the development of new therapeutic solutions.

Conclusion

Yuko Kato's contributions to pharmaceutical innovations highlight her role as a leading inventor in her field. Her patent for compounds effective in treating serious bone diseases showcases her commitment to improving health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…